Comparison to previous annual report - Top 20 : was 59.36 / now 59.71% Management : was 45.9% / now 47.17% No selling by management or Top 20, only buying.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025